评估短期富含酸盐的食补充剂对COPD内皮功能的影响:一项随机交叉研究
Fernanda Beatriz Costa Delacoste1, Cassia da Luz Goulart2, Augusto Baumhardt Guidoti1
1Graduation Program in Rehabilitation Sciences, Experimental Laboratory of Physiology Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
Respiratory medicine
|July 25, 2024
概括
食中酸盐补充剂没有改善COPD患者的内皮功能. 对于慢性阻塞性肺病的治疗效果,可能需要更高剂量或更长时间使用酸盐.
科学领域:
- 心血管研究研究心血管研究
- 肺部医学 肺部医学
- 营养科学 营养科学
背景情况:
- 内皮功能障碍是慢性阻塞性肺病 (COPD) 的一个问题.
- 已知食酸盐可以改善内皮功能.
- 对COPD患者的酸盐补充剂的研究至关重要.
研究的目的:
- 评估饮食中酸盐 (l-氨酸或甜菜) 摄入对COPD患者内皮功能的急性影响.
- 分析动脉硬度和血中酸盐水平的变化.
主要方法:
- 随机交叉研究与17名COPD患者进行.
- 三种补充手臂:l-arginine,甜菜和安慰剂,每种为14天,每种为7天的洗.
- 通过流介扩张 (FMD) 评估内皮功能;测量了血酸盐水平.
主要成果:
- 没有观察到内皮功能 (FMD,RHI) 或动脉硬 (AIx) 的显著改善.
- 血中酸盐水平在不同组或随着时间的推移而没有显著差异.
- 基线内皮功能障碍仅在少数参与者中存在.
结论:
- 在测试剂量中,急性酸盐食补充剂没有提高COPD患者的内皮功能.
- 需要进一步研究更高剂量或更长时间的酸盐补充剂.
- 目前的研究结果表明,急性酸盐治疗COPD内皮功能障碍的有效性有限.
相关概念视频
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Antianginal Drugs: Nitrates and β-Blockers
567
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
567
COPD: Management Using Bronchodilators and Corticosteroids
193
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
193
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Antihypertensive Drugs: Vasodilators
495
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
495
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K


